ClinicalTrials.gg
CompletedNCT05872945AIPROFBUpdated Nov 13, 2024

Model-based Systems for Professional Football Teams, Aimed at Optimizing Health and Performance

An observational study in Electrocardiogram and Arrhythmias, Cardiac, sponsored by RCD Mallorca SAD. Completed at 1 site in Spain. Open to male participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-11-13.

Sponsored by RCD Mallorca SAD · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
54
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

LIST OF PLANNED ORIGINAL PUBLICATIONS

  1. T wave inversion detection with machine learning to prevent sudden death in professional football players.
  2. Machine learning applied to biological parameters for control and advisory in professional football players (Machine learning applied to biological parameters for control and advisory in professional football players.)
  3. Machine learning applied to sport geolocation systems for injury prevention in professional football players.
Read the detailed description

1. Introduction The approach of this project arises from the concern to use intelligence systems artificial intelligence and machine learning in professional sports as assistance for the optimization of health and performance in professional soccer players. In professional sport, increasing physical, biological and physiological efforts are required and we need help tools.

In this regard, the proposal of several publications within the project has been raised:

  1. Detection of T-wave inversion with machine learning to prevent sudden death in professional soccer players.

    Players undergo various pre-competitive screening tests to assess their state of health, specifically one of them is a resting 12-lead electrocardiogram. Based on the waveform findings in this complementary test, the risk of a professional athlete and the need for more complementary tests can be classified (Drezner et al., 2017). Our proposal is to reanalyze these tests and subject them to a machine learning mathematical model that is capable of detecting T wave inversions in said leads and presenting the results and recommendations in accordance with international criteria for electrocardiographic study in athletes.

  2. Machine learning applied to biological parameters for control and advice in professional soccer players.

    During the season, routine analyzes are carried out to control biochemical parameters related to health and performance that fluctuate or change throughout the season: vitamin D, vitamin B12, vitamin B9, ferritin, etc. (Galan et al. ., 2012). Said data will be subjected to a machine learning procedure that can notify us of alterations in the habitual pattern of the players and that can cause alterations in performance, even generating pathologies.

  3. Machine learning applied to sports geolocation systems for the prevention of injuries in professional soccer players.

The data obtained during training sessions and matches regarding physical data such as duration, distance, distance at different speeds, training density, etc. Which are provided by sports geolocation systems, are of great importance when studying the effort and performance profile of each player. Obtaining the player's performance profile standardized according to the training day, we can detect adverse situations such as: over-training or lack of physical condition. Warning and alarm systems aimed at injury prevention can be designed. (Rossi, Pappalardo, Marcello, Javier, \& May, 2017).

2. Description The studies will be implemented by implementing artificial intelligence and machine learning systems on the physical, biological and physiological data collected during the routine sports and health activity of the professional football players in the 2019-20 and 2020-21, 2021-22, 2022-23 y 2023-24 seasons.

2.1 General Objectives

  • Evaluate the installation of artificial intelligence systems such as automatic learning to obtain models and results in the interpretation of physical, biomedical and physiological parameters of the players.
  • Develop advisory/advertising systems in the area of health and performance based on profiles.

    3. Practical application The project has great potential for practical applicability and could generate a paradigm shift, since it is based on the generation of mathematical and/or programming models that will help in health controls and sports load controls that are applied to professional soccer players. A notable aspect is the possible improvement in the calculation of the probabilistic weights of the risk factors on health and performance.

02

Conditions studied

  • Electrocardiogram
  • Arrhythmias, Cardiac

Browse trials for

Keywords

  • Artificial Intelligence
  • Performance
  • Pro Football Players
  • Sudden Death Prevention
03

In context

Arrhythmias, Cardiac

915 studies on the registry are indexed under Arrhythmias, Cardiac; 234 are open to participants now.

This study's enrollment of 54 is below the median of 200 across 426 observational studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

This is the only study on the registry with RCD Mallorca SAD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pro Football Players

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy young and professional players of legal age who play their role in professional football teams.

Exclusion criteria

Exclusion criteria:

  • Players who are not a regular part of these professional teams.
  • Players with known pathology.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
54 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Interventions

  • Diagnostic testElectrocardiogram

    Study by Artificial Intelligence the biosignal or biodata from profesional football players

    Also known as: Blood Analitycs, GPS Data

06

What researchers measure

Primary outcomes

  1. Waves Detection

    Detection waves changes in the electrocardiogram from pro football players

    Time frame: 2023-2024

07

Study locations

1 site
  • RCD Mallorca SAD
    Palma de Mallorca, 07011, Spain
08

References and documents

Study documents

  • Protocol, analysis plan and consent form · Aug 10, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The plan is to generate an anonymous ECG, blood data and GPS Data from football players and share the dataset in XML or CSV format

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: The information will be available from June 2023 onwards

Access criteria: Information that is public and available on request to researchers with an interest in physiological datasets

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2019 to primary completion in Jun 2024, 59 months.

Of 181 non-industry observational studies under Arrhythmias, Cardiac, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 109. This study's 59 months is above that.

Counting every sponsor, half of 243 studies reached it within 37 months; a quarter within 15 and three quarters within 91.

How these figures are worked out, and which studies are left out of them.

Registered
May 2, 2023
First posted
May 24, 2023
StartActual
Jul 1, 2019
Primary completionActual
Jun 1, 2024
CompletionActual
Jul 30, 2024
Last update
Nov 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05872945
Lead sponsor
RCD Mallorca SAD
Responsible party
Sponsor
First posted
May 24, 2023
Start date
Jul 1, 2019
Primary completion
Jun 1, 2024
Completion
Jul 30, 2024
Last update
Nov 13, 2024

Study contacts

Adolfo Munoz Macho, Dr.
principal investigator · RCD Mallorca SAD

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion